CE: Innovations in Acute Graft-Versus-Host Disease: Pharmacy Updates on Risk Assessment, Prevention, and Treatment

Publication
Article
Pharmacy Practice in Focus: OncologyFebruary 2021
Volume 3
Issue 1

This activity is supported by an educational grant from Incyte Corporation.

This activity is supported by an educational grant from Incyte Corporation.

EDUCATIONAL OBJECTIVES

At the completion of this activity, the participant will be able to:

  • Apply risk scoring tools for assessing grade and stage of acute graft-versus-host disease (aGVHD) in allogeneic hematopoietic stem cell transplantation (HSCT) recipients
  • Examine emerging strategies in the prevention and treatment of aGVHD
  • Maximize the role of the pharmacist of the HSCT team to improve patient outcomes

FACULTY

Nicole Watts, PharmD, BCOP

Clinical Pharmacy Specialist, Blood and Bone Marrow Transplant , University of Alabama at Birmingham Hospital , Birmingham, Alabama

TARGET AUDIENCE: Pharmacists

ACTIVITY TYPE: Application

RELEASE DATE: November 30, 2020

EXPIRATION DATE: August 30, 2021

ESTIMATED TIME TO COMPLETE ACTIVITY: 2 hours

FEE: This lesson is offered for free at www.pharmacytimes.org.

Related Videos
Pharmacist preparing high-risk chemotherapy
Image Credit: © jarun011 - stock.adobe.com
MP Studio - stock.adobe.com
Image credit: David A Litman | stock.adobe.com
Credit: AkuAku - stock.adobe.com
Portrait of young female pharmacist holding medication while using computer at pharmacy counter | Image Credit: Dragana Gordic - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.